Yes. I really must say I found Rachel's answer not properly analytic on this issue.
Let me be very frank. She said that other countries are waiting to see what Canada does before invoking their CAMR-like laws. That hypothesizes that China, India, and the European Union aren't clever enough to figure out how to do it themselves and need Canada to show the way. This is just unreal. Those are very sophisticated countries, as is Switzerland, as is Norway, and if they want to make use of their own laws passed by their own parliaments, they really don't need to watch and wait and see how Canada does it.
I'll leave it at that, but on the suggestion that there wouldn't be in the future medicines such as the second-line medicines available from those other countries that would only be available in Canada, again, that doesn't make a lot of sense. We're a relatively minor industrial country. We're small. We're no India. We're not China. That's obvious. We're not even the European Union. Thank goodness we can manufacture medicines and do it well, but so can those others, and this is inherent in the nature of globalization. There is more than one source for these things, and I would be shocked, I am shocked, to hear the advocacy that says “Although Canadian generics cost more, we want people buying those”, because that means fewer patients treated.